{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:21:22Z","timestamp":1792552882499,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.juro.2012.04.143","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T20:06:46Z","timestamp":1348517206000},"page":"422-429","source":"Crossref","is-referenced-by-count":95,"title":["Toward the Detection of Prostate Cancer in Urine: A Critical Analysis"],"prefix":"10.1097","volume":"189","author":[{"given":"Matthew","family":"Truong","sequence":"first","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Jarrard","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.04.143_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnci\/djp001","article-title":"Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context","volume":"101","author":"Draisma","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2012.04.143_bib2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.eururo.2010.03.002","article-title":"Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium","volume":"57","author":"Djavan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2008.20.3422","article-title":"Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach","volume":"28","author":"Gann","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.04.143_bib4","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.04.143_bib5","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2008.01.013","article-title":"PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance","volume":"179","author":"Nakanishi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1373\/clinchem.2005.062919","article-title":"Urine markers as possible tools for prostate cancer screening: review of performance characteristics and practicality","volume":"52","author":"M\u00fcller","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2012.04.143_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.urology.2009.03.046","article-title":"Urinary prostate cancer 3 test: toward the age of reason?","volume":"75","author":"Vlaeminck-Guillem","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.04.143_bib8","doi-asserted-by":"crossref","first-page":"e6985","DOI":"10.1371\/journal.pone.0006985","article-title":"Implications of storing urinary DNA from different populations for molecular analyses","volume":"4","author":"Cannas","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2012.04.143_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2012.04.143_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pros.21032","article-title":"Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer","volume":"70","author":"Hessels","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2012.04.143_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.humpath.2009.01.004","article-title":"Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology","volume":"40","author":"Fujita","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.juro.2012.04.143_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/dc.21344","article-title":"Morphologic features of prostatic adenocarcinoma on ThinPrep\u00ae urinary cytology","volume":"39","author":"Tyler","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.juro.2012.04.143_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/BIC.S3187","article-title":"Promoter methylation in prostate cancer and its application for the early detection of prostate cancer using serum and urine samples","volume":"2010","author":"Ahmed","year":"2010","journal-title":"Biomark Cancer"},{"key":"10.1016\/j.juro.2012.04.143_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1258\/acb.2009.009247","article-title":"Urinary proteases degrade albumin: implications for measurement of albuminuria in stored samples","volume":"47","author":"Kania","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.juro.2012.04.143_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pros.21457","article-title":"Chronic prostatitis does not influence urinary PCA3 score","volume":"72","author":"Vlaeminck-Guillem","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2012.04.143_bib16","doi-asserted-by":"crossref","first-page":"F1346","DOI":"10.1152\/ajprenal.90736.2008","article-title":"Characterizations of urinary sediments precipitated after freezing and their effects on urinary protein and chemical analyses","volume":"296","author":"Saetun","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.juro.2012.04.143_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/pros.20967","article-title":"DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection","volume":"69","author":"Payne","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2012.04.143_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/sj.bjc.6602311","article-title":"Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer","volume":"92","author":"Thuret","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2012.04.143_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00109-005-0034-0","article-title":"Quantitative assessment of DNA methylation: Potential applications for disease diagnosis, classification, and prognosis in clinical settings","volume":"84","author":"Brena","year":"2006","journal-title":"J Mol Med"},{"key":"10.1016\/j.juro.2012.04.143_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrurol.2009.261","article-title":"Urine biomarkers in prostate cancer","volume":"7","author":"Ploussard","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib21","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1200\/JCO.2005.07.009","article-title":"Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects","volume":"23","author":"Hoque","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.04.143_bib22","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/1078-0432.CCR-06-2467","article-title":"Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage","volume":"13","author":"Roupr\u00eat","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2012.04.143_bib23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4161\/epi.6.9.16376","article-title":"TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers","volume":"6","author":"Costa","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.juro.2012.04.143_bib24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0302-2838(02)00126-4","article-title":"DNA alterations in body fluids as molecular tumor markers for urological malignancies","volume":"41","author":"Goessl","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib25","first-page":"2695","article-title":"DD3(PCA3), a very sensitive and specific marker to detect prostate tumors","volume":"62","author":"de Kok","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2012.04.143_bib26","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2009.03.029","article-title":"Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram","volume":"56","author":"Chun","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2010.06.039","article-title":"Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test","volume":"58","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.juro.2009.10.003","article-title":"Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program","volume":"183","author":"Tosoian","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.04.143_bib31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1464-410X.2010.09286.x","article-title":"The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?","volume":"106","author":"Ploussard","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.04.143_bib32","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2011.08.003","article-title":"Contemporary role of prostate cancer antigen 3 in the management of prostate cancer","volume":"60","author":"Auprich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1101\/gr.110684.110","article-title":"Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing","volume":"21","author":"Pflueger","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.juro.2012.04.143_bib34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.juro.2012.04.143_bib35","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1158\/1078-0432.CCR-07-0700","article-title":"Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer","volume":"13","author":"Hessels","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2012.04.143_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1600-0463.2009.02517.x","article-title":"TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis","volume":"117","author":"Rostad","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.juro.2012.04.143_bib37","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1038\/sj.onc.1208518","article-title":"Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome","volume":"24","author":"Petrovics","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2012.04.143_bib38","first-page":"1033","article-title":"Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer","volume":"17","author":"Winnes","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.juro.2012.04.143_bib39","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1038\/sj.onc.1210237","article-title":"TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort","volume":"26","author":"Demichelis","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2012.04.143_bib40","doi-asserted-by":"crossref","first-page":"94ra72","DOI":"10.1126\/scitranslmed.3001970","article-title":"Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA","volume":"3","author":"Tomlins","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.juro.2012.04.143_bib41","doi-asserted-by":"crossref","unstructured":"Salami SS, Schmidt F, Laxman B et al: Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Urol Oncol, Epub ahead of print May 19, 2011.","DOI":"10.1016\/j.urolonc.2011.04.001"},{"key":"10.1016\/j.juro.2012.04.143_bib42","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/1078-0432.CCR-04-1919","article-title":"Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity","volume":"11","author":"Botchkina","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2012.04.143_bib43","doi-asserted-by":"crossref","first-page":"249.e1","DOI":"10.1016\/j.urology.2010.08.005","article-title":"\u03b1-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues","volume":"77","author":"Ouyang","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.04.143_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/0008-5472.CAN-07-3224","article-title":"A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer","volume":"68","author":"Laxman","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2012.04.143_bib45","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.juro.2009.01.110","article-title":"A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer","volume":"181","author":"Ouyang","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/pcan.2011.32","article-title":"Quadriplex model enhances urine-based detection of prostate cancer","volume":"14","author":"Jamaspishvili","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2012.04.143_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2010.11.026","article-title":"A panel of TMPRSS2:ERG fusion transcript markers for urine-based prostate cancer detection with high specificity and sensitivity","volume":"59","author":"Nguyen","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.04.143_bib48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.urology.2004.10.003","article-title":"Urinary\/serum prostate-specific antigen ratio: comparison with free\/total serum prostate-specific antigen ratio in improving prostate cancer detection","volume":"65","author":"Irani","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.04.143_bib49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0090-4295(97)00324-5","article-title":"Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer","volume":"50","author":"Pannek","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.04.143_bib50","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1158\/1078-0432.CCR-08-1136","article-title":"Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species","volume":"14","author":"Roy","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712049634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712049634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.04.143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:02:29Z","timestamp":1651201349000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.04.143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1016\/j.juro.2012.04.143"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.04.143","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}